Mirum Pharmaceuticals (MIRM) News Today $73.79 -0.40 (-0.54%) Closing price 04:00 PM EasternExtended Trading$73.72 -0.07 (-0.09%) As of 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MIRM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Millennium Management LLC Has $21.59 Million Stake in Mirum Pharmaceuticals, Inc. $MIRMSeptember 15 at 3:31 AM | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $77.00September 15 at 3:07 AM | americanbankingnews.comMirum Pharmaceuticals (NASDAQ:MIRM) Given New $77.00 Price Target at JPMorgan Chase & Co.September 14 at 8:26 AM | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells $728,023.78 in StockSeptember 13 at 6:38 AM | insidertrades.comMirum Pharmaceuticals price target raised to $77 from $53 at JPMorganSeptember 12, 2025 | msn.comDemystifying Mirum Pharmaceuticals: Insights From 6 Analyst ReviewsSeptember 12, 2025 | benzinga.comWoodline Partners LP Acquires 161,867 Shares of Mirum Pharmaceuticals, Inc. $MIRMSeptember 12, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Sets New 12-Month High - Still a Buy?September 11, 2025 | marketbeat.comMirum Pharmaceuticals completes enrollment in VISTAS study of volixibatSeptember 9, 2025 | msn.comMirum Pharmaceuticals, Inc. (MIRM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comMirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS StudySeptember 8, 2025 | finance.yahoo.comMirum Pharmaceuticals, Inc. $MIRM Shares Purchased by Adage Capital Partners GP L.L.C.September 8, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Stake Lessened by Eventide Asset Management LLCSeptember 6, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Hits New 12-Month High - Should You Buy?September 5, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Stake Boosted by Frazier Life Sciences Management L.P.September 4, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Position Trimmed by Northern Trust CorpSeptember 4, 2025 | marketbeat.comPDT Partners LLC Acquires 23,782 Shares of Mirum Pharmaceuticals, Inc. $MIRMSeptember 3, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $13.38 Million Stock Position in Mirum Pharmaceuticals, Inc. $MIRMSeptember 3, 2025 | marketbeat.comRafferty Asset Management LLC Boosts Stock Position in Mirum Pharmaceuticals, Inc. $MIRMSeptember 2, 2025 | marketbeat.comJump Financial LLC Decreases Holdings in Mirum Pharmaceuticals, Inc. $MIRMSeptember 2, 2025 | marketbeat.comRaymond James Financial Inc. Sells 7,294 Shares of Mirum Pharmaceuticals, Inc. $MIRMSeptember 2, 2025 | marketbeat.com52,430 Shares in Mirum Pharmaceuticals, Inc. $MIRM Acquired by Kodai Capital Management LPSeptember 1, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Shares Sold by Wellington Management Group LLPSeptember 1, 2025 | marketbeat.comTema Etfs LLC Lowers Stake in Mirum Pharmaceuticals, Inc. $MIRMAugust 31, 2025 | marketbeat.comNext Century Growth Investors LLC Purchases 31,089 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 7,592 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 29, 2025 | marketbeat.comAffinity Asset Advisors LLC Trims Stake in Mirum Pharmaceuticals, Inc. $MIRMAugust 28, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Stock Position Raised by Capital Fund Management S.A.August 28, 2025 | marketbeat.comMirum Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 27, 2025 | businesswire.comMirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year High - Time to Buy?August 27, 2025 | marketbeat.comWall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to BuyAugust 27, 2025 | marketbeat.comAlphaQuest LLC Purchases 20,751 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 26, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $14.77 Million Stock Position in Mirum Pharmaceuticals, Inc. $MIRMAugust 26, 2025 | marketbeat.comInvesco Ltd. Boosts Stock Position in Mirum Pharmaceuticals, Inc. $MIRMAugust 25, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of "Buy" by BrokeragesAugust 24, 2025 | marketbeat.comVanguard Group Inc. Purchases 115,327 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 24, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. $MIRM Shares Sold by Candriam S.C.A.August 23, 2025 | marketbeat.comEntryPoint Capital LLC Makes New $436,000 Investment in Mirum Pharmaceuticals, Inc. $MIRMAugust 23, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Hits New 1-Year High - What's Next?August 21, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 203,489 Shares of Mirum Pharmaceuticals, Inc. $MIRMAugust 21, 2025 | marketbeat.com15,691 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Bought by Fox Run Management L.L.C.August 19, 2025 | marketbeat.comNuveen LLC Buys New Shares in Mirum Pharmaceuticals, Inc. $MIRMAugust 19, 2025 | marketbeat.comWall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to "Strong-Buy"August 18, 2025 | marketbeat.comE Fund Management Co. Ltd. Makes New $218,000 Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)August 17, 2025 | marketbeat.comDeutsche Bank AG Purchases 71,421 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)August 16, 2025 | marketbeat.comInsider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) CEO Sells 40,000 Shares of StockAugust 14, 2025 | marketbeat.comMirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 12-Month High - Here's WhyAugust 14, 2025 | marketbeat.comChristopher Peetz Sells 40,000 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) StockAugust 13, 2025 | insidertrades.comMirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Up 9.1% After Analyst UpgradeAugust 12, 2025 | marketbeat.comStifel Nicolaus Reiterates "Buy" Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)August 12, 2025 | marketbeat.com Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MIRM Media Mentions By Week MIRM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRM News Sentiment▼0.370.92▲Average Medical News Sentiment MIRM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRM Articles This Week▼136▲MIRM Articles Average Week Get the Latest News and Ratings for MIRM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ascendis Pharma A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today QIAGEN News Today BridgeBio Pharma News Today Moderna News Today Verona Pharma PLC American Depositary Share News Today Elanco Animal Health News Today Roivant Sciences News Today Revolution Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MIRM) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
